References Abrahami D, DAndrea E, Yin H, Kim SC, Paik JM, Wexler D, et al
Lixisenatide, a novel GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus
Synergy of Dual Engagement Preclinical research suggests that simultaneous GIPR and GLP-1R activation produces metabolic effects that exceed the sum of either pathway alone a finding that has driven sustained interest in dual-agonist research compounds
[4] Boost Your Metabolism : All cells in your body with a nucleus, receive stimulus that releases cellular energy in the form of ATP (adenosine triphosphate), improving mitochondrial functioning, promoting cellular repair and regeneration this is what causes an elevation in metabolic rate with RLT, allowing you to burn more calories even when youre at rest, making weight management more effortless
Patients should also tell surgical and anesthesia teams about GLP-1 or tirzepatide treatment before procedures involving general anesthesia or deep sedation because current labeling includes warnings related to delayed gastric emptying and pulmonary aspiration
